JPMORGAN CHASE & CO - 30 Apr 2025 SCHEDULE 13G/A Report for KEROS THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (KROS)

Filing Manager: JPMORGAN CHASE & CO
Reporting Manager: JPMORGAN CHASE & CO.
Security: KEROS THERAPEUTICS, INC. Common Stock, $0.0001 par value per share
Symbol: KROS
Disclosed Ownership: 113,803 shares
Ownership: 0.2%
Form type: SCHEDULE 13G/A
Filing time: 05 May 2025, 14:03:05 UTC
Date of event: 30 Apr 2025
Previous filing: 02 May 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JPMORGAN CHASE & CO.	0.2%	113,803	113,803	0	Rachel Tsvaygoft	Vice President